SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018700
Filing Date
2023-11-13
Accepted
2023-11-13 08:31:20
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmt-20230930x10q.htm   iXBRL 10-Q 1780850
2 EX-31.1 sgmt-20230930xex31d1.htm EX-31.1 11886
3 EX-31.2 sgmt-20230930xex31d2.htm EX-31.2 12848
4 EX-32.1 sgmt-20230930xex32d1.htm EX-32.1 9497
  Complete submission text file 0001558370-23-018700.txt   7491304

Data Files

Seq Description Document Type Size
5 EX-101.SCH sgmt-20230930.xsd EX-101.SCH 42452
6 EX-101.CAL sgmt-20230930_cal.xml EX-101.CAL 36226
7 EX-101.DEF sgmt-20230930_def.xml EX-101.DEF 228493
8 EX-101.LAB sgmt-20230930_lab.xml EX-101.LAB 417127
9 EX-101.PRE sgmt-20230930_pre.xml EX-101.PRE 335974
61 EXTRACTED XBRL INSTANCE DOCUMENT sgmt-20230930x10q_htm.xml XML 1387585
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 231395426
SIC: 2834 Pharmaceutical Preparations